Nathalie Scholler

Penn Ovarian Cancer Research Center, University of Pennsylvania-School of Medicine

Affiliated withUniversity of Pennsylvania-School of Medicine

Research Area

Biography

Nathalie Scholler has not added Biography.
If you are Nathalie Scholler and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 18	2010

Other Publications

Article	Year
Cutting edge: CD83 regulates the development of cellular immunity. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 11884422	2002
Plasmid-based vaccines encoding rat neu and immune stimulatory molecules can elicit rat neu-specific immunity. Molecular cancer therapeutics\| PubMed ID: 14578464	2003
Bead-based ELISA for validation of ovarian cancer early detection markers. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16609024	2006
Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery. Cancer letters\| PubMed ID: 16677756	2007
Method for generation of in vivo biotinylated recombinant antibodies by yeast mating. Journal of immunological methods\| PubMed ID: 17113097	2006
Development and in vitro validation of anti-mesothelin biobodies that prevent CA125/Mesothelin-dependent cell attachment. Cancer letters\| PubMed ID: 17560019	2007
Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISA. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 18451228	2008
A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS medicine\| PubMed ID: 18547137	2008
Systematic evaluation of candidate blood markers for detecting ovarian cancer. PloS one\| PubMed ID: 18612378	2008
Combining a symptoms index with CA 125 to improve detection of ovarian cancer. Cancer\| PubMed ID: 18615684	2008
Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discovery. Journal of translational medicine\| PubMed ID: 18652693	2008
Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 18768519	2008
Maternal mortality from systemic illness: unraveling the contribution of the immune response. American journal of obstetrics and gynecology\| PubMed ID: 19318152	2009
Oncology biomarkers--second annual GTCbio conference. Biomarkers for disease detection and therapeutics monitoring. 19-20 January 2009, Miami, FL, USA. IDrugs : the investigational drugs journal\| PubMed ID: 19350459	2009
Use of high density antibody arrays to validate and discover cancer serum biomarkers. Molecular oncology\| PubMed ID: 19383305	2007
Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 19423517	2009
Beyond CA125: the coming of age of ovarian cancer biomarkers. Are we there yet? Biomarkers in medicine\| PubMed ID: 19684876	2009
Antifouling surface layers for improved signal-to-noise of particle-based immunoassays. Langmuir : the ACS journal of surfaces and colloids\| PubMed ID: 19928944	2009
Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer. Gynecologic oncology\| PubMed ID: 19945742	2010
Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study. Journal of the National Cancer Institute\| PubMed ID: 20042715	2010
CA125 in ovarian cancer. Biomarkers in medicine\| PubMed ID: 20477371	2007
Rapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platform. Journal of immunological methods\| PubMed ID: 20837020	2011
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer prevention research (Philadelphia, Pa.)\| PubMed ID: 21372036	2011
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer prevention research (Philadelphia, Pa.)\| PubMed ID: 21372037	2011
Novel surface targets and serum biomarkers from the ovarian cancer vasculature. Cancer biology & therapy\| PubMed ID: 21617380	2011
Potential role of HE4 in multimodal screening for epithelial ovarian cancer. Journal of the National Cancer Institute\| PubMed ID: 21917606	2011
Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer. Gynecologic oncology\| PubMed ID: 22037318	2012
Redirected Antitumor Activity of Primary Human Lymphocytes Transduced With a Fully Human Anti-mesothelin Chimeric Receptor. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 22127019	2011
Mannose receptor (MR) engagement by mesothelin GPI anchor polarizes tumor-associated macrophages and is blocked by anti-MR human recombinant antibody. PloS one\| PubMed ID: 22163010	2011
Oncology biomarkers for gynecologic malignancies. Frontiers in bioscience (Elite edition)\| PubMed ID: 22201939	2012
A universal strategy for adoptive immunotherapy of cancer through use of a novel T cell antigen receptor. Cancer research\| PubMed ID: 22315351	2012